Closely held PharmaJet has highlighted a peer-reviewed publication in the AI-powered open science publishing platform Qeios, which evaluated the evidence on implementation of novel technologies for intradermal (ID)...
Search results for - PharmaJet
PharmaJet Tropis Needle-free Injection System selected to deliver 1.4 million polio vaccine doses in Nigeria
Closely held PharmaJet announced that its WHO-prequalified Tropis ID Needle-free Injection System will be used to deliver approximately 1.4 million doses of fractional inactivated polio vaccine (fIPV), in partnership...
PharmaJet’s Needle-free Injection System selected for DNA immunotherapy in advanced melanoma
Closely held PharmaJet announced that its partner, Scancell, has reported updated Phase 2 clinical data from the SCOPE study in unresectable advanced melanoma demonstrating a progression-free survival (PFS) rate of 74%...
PharmaJet inks agreement with EVA Pharma to provide needle-free injection systems to support routine polio immunization in Egypt
Closely held PharmaJet has announced that it has signed a distribution agreement with ATR, an affiliate to closely held EVA Pharma. The agreement, signed in Frankfurt at the CPHI meeting on October 30, 2025, includes...
PharmaJet’s Tropis ID selected for Pakistan’s polio campaign
Closely held PharmaJet has announced that its WHO prequalified Tropis ID Needle-free Injection System will be used exclusively in Pakistan’s latest polio immunization campaign to deliver vaccines to 1.8 million children...
PharmaJet initiates development of needle-free injection pens for home use
Closely held PharmaJet has announced that it is expanding its needle-free injection portfolio with the development of a suite of proprietary, needle-free, self-injector pens. The single-use and reusable needle-free...
WHO, UNICEF rollout Afghanistan polio vaccination campaign with PharmaJet Tropis ID delivery system
Closely held PharmaJet has announced that its WHO prequalified Tropis ID delivery system will be used to support a polio eradication campaign sponsored by the National Emergency Operation Center (NEOC) Afghanistan...
PharmaJet enters MOU for needle-free vaccine delivery in Egypt
Closely held PharmaJet has announced the signing of a Memorandum of Understanding (MOU) with the Egyptian Unified Procurement Authority (UPA) and closely held EVA Pharma. The agreement aims to explore the integration of...
PharmaJet and Immuno Cure partner to advance needle-free HIV therapeutic DNA vaccine
Closely held PharmaJet announced that it has signed an agreement with closely held Immuno Cure, a developer of DNA vaccines. Under the agreement, Immuno Cure will use PharmaJet’s Tropis Intradermal (ID) Needle-Free...
Vaccines publishes key benefits of PharmaJet Tropis ID vaccine over IM SoC
Closely held PharmaJet announced that the results of an implementation research study—titled Evaluating the impact of needle-free delivery of inactivated polio vaccine on Nigeria’s routine immunization program: An...
